|Bid||4.1200 x 1000|
|Ask||5.0000 x 800|
|Day's Range||4.0800 - 4.4000|
|52 Week Range||2.7600 - 10.0800|
|Beta (5Y Monthly)||2.45|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
On a per-share basis, the San Diego-based company said it had a loss of 18 cents. In the final minutes of trading on Monday, the company's shares hit 53 cents. A year ago, they were trading at $2.30. _____ ...
Atyr Pharma (LIFE) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
The San Diego-based company said it had a loss of 21 cents per share. For the year, the company reported that its loss narrowed to $34.5 million, or $1.15 per share. In the final minutes of trading on ...